Electronic searches |
---|
Unless otherwise stated, search terms were free text terms; exp = exploded MeSH: Medical Subject Heading (Medline medical index term); the dollar sign ($) stands for any character(s); the question mark (?) = substitute for one or no characters; ab = abstract; ti = titel; ot = original titel; pt = publication type; sh = MeSH: Medical subject heading (MEDLINE medical index term); adj = adjacency. |
I. Impaired glucose tolerance / impaired fasting blood glucose: |
1.exp Glucose Intolerance/ |
2.exp Diabetes Mellitus/pc [Prevention & Control] |
3.exp Glucose Tolerance Test/ |
4.exp Insulin Resistance/ |
5.exp Metabolic Syndrome X/ |
6.IGT.ab,ti,ot. |
7.glucose intoleranc$.ab,ti,ot. |
8.(glucose adj tolerance test$).ab,ti,ot. |
9.OGTT.ab,ti,ot. |
10.insulin$ resistanc$.ab,ti,ot. |
11.(impaired fasting and (blood or glucos$ or gly?emia$)).ab,ti,ot. |
12.(impaired glucose and (toleranc$ or stat$ or respons$ or control$)).ab,ti,ot. |
13.(impaired glucose and (regul$ or metab$ or homeost$)).ab,ti,ot. |
14.(reduced glucose and (metabol$ or toleranc$)).ab,ti,ot. |
15.glucose intolerant$.ab,ti,ot. |
16.pr?ediabet$.ab,ti,ot. |
17.pr?e diabet$.ab,ti,ot. |
18.metabolic syndr$.ab,ti,ot. |
19.syndrom$ X.ab,ti,ot. |
20.((borderline or mild or chemical) adj diabet$).ab,ti,ot. |
21.((impaired insulin$ or reduced insulin$) adj secret$).ab,ti,ot. |
22.or/1-21 |
II. Chinese herbal medicines: |
23.exp Medicine, Oriental Traditional/ |
24.exp Drugs, Chinese Herbal/ |
25.exp Plants, Medicinal/ |
26.exp Plant Extracts/ |
27.exp Phytotherapy/ |
28.exp Medicine, Ayurvedic/ |
29.integrative medicin$.ab,ti,ot. |
30.(medicin$ adj5 (chines$ or oriental$ or tibetan$)).ab,ti,ot. |
31.(herbal medicin$ or medicin$ herbal$).ab,ti,ot. |
32.(plant$ medicin$ or medicin$ plant$).ab,ti,ot. |
33.plant$ extract$.ab,ti,ot. |
34.phytotherap$.ab,ti,ot. |
35.medicine ayurvedic.ab,ti,ot. |
36.(chinese adj (herb$ or drug$ or formul$ or plant$ or presri$ or remed$ or materia medica)).ab,ti,ot. |
37.((herb$ or drug$ or formul$ or plant$ or presri$ or remed$ or materia medica) adj chinese).ab,ti,ot. |
38.((chines$ or oriental$ or tibetan$) adj medicine$).ab,ti,ot. |
39.or/23-38 |
III. Impaired glucose tolerance/Impaired fasting blood glucose and Chinese herbal medicine: |
40.22 and 39 |
IV. RCT / CCT (sensitive search): |
Part 1: |
41.randomized controlled trial.pt. |
42.controlled clinical trial.pt. |
43.randomized controlled trials.sh. |
44.random allocation.sh. |
45.double-blind method.sh. |
46.single-blind method.sh. |
47.or/41-46 |
Part 2: |
48.clinical trial.pt. |
49.exp clinical trials/ |
50.(clinic$ adj25 trial$).ab,ti,ot. |
51.((singl$ or doubl$ or trebl$ or tripl$) adj (mask$ or blind$)).ab,ti,ot. |
52.placebos.sh. |
53.placebo$.ab,ti,ot. |
54.random$.ab,ti,ot. |
55.research design.sh. |
56.(latin adj square).ab,ti,ot. |
57.or/48-56 |
Part 3: |
58.comparative study.pt. |
59.exp evaluation studies/ |
60.follow-up studies.sh. |
61.prospective studies.sh. |
62.(control$ or prospectiv$ or volunteer$).ab,ti,ot. |
63.cross-over studies.sh. |
64.or/58-63 |
65.47 or 57 or 64 |
V. Meta-analyses, systematic reviews, health technology assessments: |
66.exp meta-analysis/ |
67.exp Review Literature/ |
68.meta-analysis.pt. |
69.review.pt. |
70.or/66-69 |
71.letter.pt. |
72.comment.pt. |
73.editorial.pt. |
74.historical-article.pt. |
75.or/71-74 |
76.70 not 75 |
77.((systematic$ or quantitativ$ or methodologic$) adj (review$ or overview$)).ab,ti,ot. |
78meta?anal$.ab,ti,ot. |
79.(integrativ$ research review$ or research integration$).ab,ti,ot. |
80.quantitativ$ synthes$.ab,ti,ot. |
81.(pooling$ or pooled analys$ or mantel$ haenszel$).ab,ti,ot. |
82.(peto$ or der?simonian$ or fixed effect$ or random effect$).ab,ti,ot. |
83.or/77-82 |
84.76 or 83 |
VI. Impaired glucose tolerance / impaired fasting blood glucose AND Chinese herbal medicine AND RCTs / CCTs: |
85.40 and 65 |
VII. Impaired glucose tolerance / impaired fasting blood glucose AND Chinese herbal medicine AND systematic reviews: |
86.40 and 85 |
VIII. VI OR VII: |
87.85 or 86 |
88.limit 87 to animal |
89.limit 87 to human |
90.88 not 89 |
91.87 not 90 |
References:
Robinson KA, Dickersin K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. International Journal of Epidemiology 2002;31(1):150-3.
Van de Laar FA, Lucassen PLBJ, Akkermans RP, Van de Lisdonk EH, De Grauw WJC. Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose. In: Cochrane Database of Systematic Reviews, Issue 4, 2004.